Roth MKM: Maintains New Pacific Metals (NEWP.US) rating, adjusted from buy to buy rating, and adjusted target price from $6.00 to $6.00.
- Headlines
- Roth MKM: Maintains New Pacific Metals (NEWP.US) rating, adjusted from buy to buy rating, and adjusted target price from $6.00 to $6.00.
Roth MKM：维持New Pacific Metals(NEWP.US)评级，由买入调整至买入评级, 目标价由6.00美元调整至6.00美元。
Roth MKM: Maintains New Pacific Metals (NEWP.US) rating, adjusted from buy to buy rating, and adjusted target price from $6.00 to $6.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
15:38
China Galaxy Securities New Development Research Institute established an International ESG Research Center.
CGS-5.26%
15:37
Anhui Liuguo Chemical: Received a dividend payment of 17.4521 million yuan from an associated company.
Anhui Liuguo Chemical-3.93%
15:36
Orient Securities maintains a "Strong Buy" rating for Marubi Biotechnology, continuing to advance its layout in the medical beauty Sector.
Guangdong Marubi Biotechnology-1.10%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.